Matthew Henn PhD

Company: Seres Therapeutics
Job title: Chief Scientific Officer
Seminars:
Microbiome Therapeutics to Transform the Treatment of Antimicrobial Resistant Infections 5:00 pm
day: Day Two
Company: Seres Therapeutics
Job title: Chief Scientific Officer
day: Day Two